IBDEI115 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16559,0)
 ;;=D53.9^^88^879^181
 ;;^UTILITY(U,$J,358.3,16559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16559,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,16559,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,16559,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,16560,0)
 ;;=D47.4^^88^879^182
 ;;^UTILITY(U,$J,358.3,16560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16560,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,16560,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,16560,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,16561,0)
 ;;=D59.1^^88^879^29
 ;;^UTILITY(U,$J,358.3,16561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16561,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Other
 ;;^UTILITY(U,$J,358.3,16561,1,4,0)
 ;;=4^D59.1
 ;;^UTILITY(U,$J,358.3,16561,2)
 ;;=^5002324
 ;;^UTILITY(U,$J,358.3,16562,0)
 ;;=D51.3^^88^879^196
 ;;^UTILITY(U,$J,358.3,16562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16562,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,16562,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,16562,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,16563,0)
 ;;=D77.^^88^879^58
 ;;^UTILITY(U,$J,358.3,16563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16563,1,3,0)
 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
 ;;^UTILITY(U,$J,358.3,16563,1,4,0)
 ;;=4^D77.
 ;;^UTILITY(U,$J,358.3,16563,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,16564,0)
 ;;=D58.2^^88^879^84
 ;;^UTILITY(U,$J,358.3,16564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16564,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,16564,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,16564,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,16565,0)
 ;;=C88.8^^88^879^106
 ;;^UTILITY(U,$J,358.3,16565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16565,1,3,0)
 ;;=3^Malig Immunoproliferative Diseases,Other
 ;;^UTILITY(U,$J,358.3,16565,1,4,0)
 ;;=4^C88.8
 ;;^UTILITY(U,$J,358.3,16565,2)
 ;;=^5001750
 ;;^UTILITY(U,$J,358.3,16566,0)
 ;;=D70.8^^88^879^179
 ;;^UTILITY(U,$J,358.3,16566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16566,1,3,0)
 ;;=3^Neutropenia,Other
 ;;^UTILITY(U,$J,358.3,16566,1,4,0)
 ;;=4^D70.8
 ;;^UTILITY(U,$J,358.3,16566,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,16567,0)
 ;;=D59.4^^88^879^180
 ;;^UTILITY(U,$J,358.3,16567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16567,1,3,0)
 ;;=3^Nonautoimmune Hemolytic Anemias,Other
 ;;^UTILITY(U,$J,358.3,16567,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,16567,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,16568,0)
 ;;=D69.59^^88^879^186
 ;;^UTILITY(U,$J,358.3,16568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16568,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,16568,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,16568,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,16569,0)
 ;;=C22.7^^88^879^47
 ;;^UTILITY(U,$J,358.3,16569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16569,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,16569,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,16569,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,16570,0)
 ;;=D75.89^^88^879^57
 ;;^UTILITY(U,$J,358.3,16570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16570,1,3,0)
 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
 ;;^UTILITY(U,$J,358.3,16570,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,16570,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,16571,0)
 ;;=D47.Z9^^88^879^178
